Despite a recent dip, Haemonetics' robust financials hint at potential long-term stock value growth. High ROE and profit reinvestment suggest promising earnings growth, with analysts predicting continued expansion.
Despite the falling share price, the consistent growth in revenue and EPS could present an investment opportunity if the stock has fallen unfairly. Market expectations may have been unreasonable in the past.
Shareholders appear to hang onto Haemonetics, expecting it to keep beating market trends, due to its projected solid growth. Despite a high P/E, the predicted limited risk of an earnings drop keeps the share price stable.
Top stocks this week 1.$必能寶(PBI.US)$- institutional investor left to invest elsewhere is why its down after its 4th ER beat in a row. Pt raised to 11.00 oversold 2.$Casa Systems Inc(CASA.US)$- in about the same boat as PBI. Pt-11.00 oversold 3.$美國血液技術(HAE.US)$way oversold. very little risk of any more backsliding 4.$Clover Health(CLOV.US)$Almost 40% shorted now. Ready to squeeze or make a run at 13.70.
美國血液技術股票討論區
目前市盈率38,估值比較合理,吸引力不大。
In reaction to earnings/guidance:
• $Gambling.com(GAMB.US)$ +5.5%, $百度(BIDU.US)$ +3.6%, $百思買(BBY.US)$ +2.4%, $海科航空(HEI.US)$ +1.4%, $必樂透(BIG.US)$ +0.6%
Other news:
• $FREYR Battery(FREY.US)$ +11.4% (announces the execution of 38 GWh Li-Ion Battery binding cell sales agreement; enters into module & pack JV for energy storage solutions with Nidec)
• $Avid Technology(AVID.US)$ +9.6% (to join S&P SmallCap 600)
• $RVL Pharmaceuticals(RVLP.US)$ +2.3% (Re...
In reaction to earnings/guidance:
• $The Trade Desk(TTD.US)$+17%, $Workiva(WK.US)$ +15.3%, $Arlo Technologies(ARLO.US)$ +12%, $Array Technologies(ARRY.US)$ +10.3%, $Everbridge(EVBG.US)$ +9.7%, $Catalyst Pharmaceuticals(CPRX.US)$ +9.4%, $奧洛茲美醫療(HALO.US)$ +8.7%, $Velo3D(VLD.US)$ +7.6%, $CyberArk(CYBR.US)$ + 6.2%, $美國血液技術(HAE.US)$ +5.8%, $Jackson Financial(JXN.US)$ +5.7% (also increases dividend), $Axon Enterprise(AXON.US)$ +4.8%,...
1. $必能寶(PBI.US)$ - institutional investor left to invest elsewhere is why its down after its 4th ER beat in a row. Pt raised to 11.00 oversold
2. $Casa Systems Inc(CASA.US)$- in about the same boat as PBI. Pt-11.00 oversold
3. $美國血液技術(HAE.US)$ way oversold. very little risk of any more backsliding
4. $Clover Health(CLOV.US)$ Almost 40% shorted now. Ready to squeeze or make a run at 13.70.
暫無評論